SCHEMBL15977504

SCHEMBL15977504

c1cnc(-c2ccc3c(-c4cc5ccccc5c5ccccc45)c4ccccc4c(-c4cccc5ccccc45)c3c2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.39
HTR2C P28335 1/20 0.39
ALDH1A1 P00352 5/20 0.37
HPGD P15428 5/20 0.37
HSD17B10 Q99714 5/20 0.37
MAPK1 P28482 5/20 0.37
MAPT P10636 5/20 0.37
KDM4E B2RXH2 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
TP53 P04637 2/20 0.37
SOS1 Q07889 1/20 0.37
TSHR P16473 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
CASP1 P29466 1/20 0.37
HIF1A Q16665 1/20 0.37
LMNA P02545 2/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.35
GSK3B P49841 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977804 0.93 CYP11B1 (0.44) CYP11B1ALDH1A1HPGDHSD17B10MAPK1
SCHEMBL15977707 0.93 HTR2C (0.43) HTR2CALDH1A1HPGDHSD17B10MAPK1
SCHEMBL15977566 0.88 CYP11B1 (0.43) CYP11B1ALDH1A1HPGDMAPK1MAPT
SCHEMBL15977807 0.88 CYP11B1 (0.43) CYP11B1ALDH1A1HPGDMAPK1MAPT
SCHEMBL15977687 0.87 SMN1; SMN2 (0.41) CYP11B1ALDH1A1HPGDHSD17B10MAPK1
SCHEMBL15977915 0.85 CYP11B1 (0.38) CYP11B1ALDH1A1HPGDHSD17B10MAPK1
SCHEMBL15977620 0.85 MAPK1 (0.42) CYP11B1HTR2CALDH1A1HPGDHSD17B10
SCHEMBL15977805 0.85 HDAC8 (0.42) HTR2CALDH1A1HPGDHSD17B10MAPK1
SCHEMBL15977841 0.84 ALDH1A1 (0.44) CYP11B1ALDH1A1HPGDHSD17B10MAPK1
SCHEMBL15977510 0.82 KDM4E (0.40) CYP11B1HTR2CALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CYP11B1 1241/4885HTR2C 4541/4885ALDH1A1 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.